| | Application no. and date | 09752688.3 (espacenet)  (Federated)  (European Patent Register), 20091113 |  | Patent/reg. no. and date | DK/EP 2358675, 20121003 |  | Publication date | 20110824 |  | Priority no. and date | US 114541 P, 20081114 |  | EP pub. no. and date | EP 2358675 20110824 |  | Effective date |  |  | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard South San Francisco, CA 94080, US
 |  | Applicant ref. no. | 145585 |  | Inventor | LONG, Daniel D., 4358 23rd Street San Francisco
 California 94114, US,
 STANGELAND, Eric L., 896 Corona Drive
 Pacifica
 California 94044, US,
 PATTERSON, Lori Jean, 3 Whitney Street
 San Francisco
 California 94131, US,
 ZIPFEL, Sheila, 112 E. Middlefield Road
 Unit B
 Mountain View
 California 94043, US
 |  | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K |  | Opponent |  |  | IPC Class | A61K 31/4409 (2006.01) ,  A61P 25/00 (2006.01) ,  C07D 211/22 (2006.01) |  | Title | 4-[2-(2-Fluorphenoxymethyl)phenyl]piperidinforbindelser |  | Int. application no. | US2009064308 |  | Int. publication no. | WO2010056941 |  | Related patent (certificate) |  |  | Status | DK/EP patent |  | Pædiatrisk forlængelse | - |  | Udløbsdato for pædiatrisk forlængelse | - | 
 |